Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Neuroscience Letters|April 22, 2005
Production of NGF, BDNF and GDNF in mouse astrocyte cultures is strongly enhanced by a cerebral vasodilator, ifenprodilMisao Toyomoto, Seiji Inoue, Kiyoe Ohta, et al.
Pharmacology|May 27, 2004
Cabergoline stimulates synthesis and secretion of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor by mouse astrocytes in primary cultureKiyoe Ohta, Aya Fujinami, Sadako Kuno, et al.
Neuroscience Letters|July 31, 2002
The novel catecholaminergic and serotoninergic activity enhancer R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane up-regulates neurotrophic factor synthesis in mouse astrocytesKiyoe Ohta, Mitsuhiro Ohta, Ikuko Mizuta, et al.
Clinical Biochemistry|April 12, 2008
Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistanceAya Fujinami, Kiyoe Ohta, Hiroshi Obayashi, et al.
Obesity (Silver Spring, Md.)|March 31, 2006
Resistin concentrations in murine adipose tissue and serum measured by a new enzyme immunoassayAya Fujinami, Kiyoe Ohta, Hidehito Matsui, et al.
Pharmacology|October 18, 2005
Effect of atorvastatin on in vitro expression of resistin in adipocytes and monocytes/macrophages and effect of atorvastatin treatment on serum resistin levels in patients with type 2 diabetesYukiko Ichida, Goji Hasegawa, Michiaki Fukui, et al.
Biological & Pharmaceutical Bulletin|July 31, 2022
Purification of Emu IgY for Therapeutic and Diagnostic Use Based on Monoclonal Secondary Antibodies Specific to Emu IgYKouya Yamaki, Kiyoe Ohta, Norihiro Kobayashi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 23, 2003
Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetesAya Fujinami, Hiroshi Obayashi, Kiyoe Ohta, et al.
Internal Medicine (Tokyo, Japan)|November 6, 2012
An ocular form of myasthenia gravis with a high titer of anti-MuSK antibodies during a long-term follow-upAi Hosaka, Hiroshi Takuma, Kiyoe Ohta, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 17, 2009
[Effects of acetylcholinesterase inhibitors on patients with MuSK antibody positive myasthenia gravis]Tetsuro Konishi, Masayuki Kousaka, Kentarou Yamakawa, et al.
Pageof 9